Identification and Validation of a Novel Antibacterial Compound MZ-01 against Methicillin-Resistant <i>Staphylococcus aureus</i>
The discovery of new classes of antibiotics is slow, and it is being greatly outpaced by the development of bacterial resistance. This disparity places us in an increasingly vulnerable position because we are running out of safe and effective therapeutic options to treat antibiotic-resistant infecti...
Main Authors: | Junshu Yang, Christopher Brown, Wayland Noland, Timothy J. Johnson, Yinduo Ji |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/11/11/1550 |
Similar Items
-
Persistent Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia: Host, Pathogen, and Treatment
by: Joshua B. Parsons, et al.
Published: (2023-02-01) -
Glycosides of Nadifloxacin—Synthesis and Antibacterial Activities against Methicillin-Resistant <em>Staphylococcus aureus</em>
by: Mark Hutchins, et al.
Published: (2022-02-01) -
Clinical Presentation and Management of Methicillin-Resistant <i>Staphylococcus aureus</i> Pericarditis—Systematic Review
by: Milan Radovanovic, et al.
Published: (2022-03-01) -
Synergy between Phage Sb-1 and Oxacillin against Methicillin-Resistant <i>Staphylococcus aureus</i>
by: Kevin Simon, et al.
Published: (2021-07-01) -
The Epidemiology of Animal-Associated Methicillin-Resistant <i>Staphylococcus aureus</i>
by: Martyna Kasela, et al.
Published: (2023-06-01)